GEHC in the 13F filings
Ge Healthcare Technologies I · CUSIP 36266G107
- Quarter end
- 30 Sep 2023
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 13 Nov 2023
- Managers listing it
- 14
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q2 2023 and Q3 2023; 13 listed it in both
- Shares listed
- 96,681,106
- combined, among listed positions
- Reported value
- $6.6bn
- combined, at the quarter end
Managers listing GEHC in Q3 2023
14 of 14 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 5,048,262 shares now+889,297
- Capital Research Global Investorsexisting position · 49,943,153 shares now+373,364
- AQR Capital Management LLCexisting position · 560,547 shares now+161,373
- Davidson Kempner Capital Management LPexisting position · 160,000 shares now+128,315
- Winton Group Ltdexisting position · 11,505 shares now+2,259
Reductions
- T. Rowe Price Associates Incexisting position · 12,259,394 shares now-3,517,555
- Fidelity (FMR LLC)existing position · 8,585,805 shares now-962,729
- Dodge & Coxexisting position · 17,132,992 shares now-172,432
- Arrowstreet Capital LPexisting position · 485,681 shares now-171,982
- Janus Henderson Group Ltdexisting position · 893,323 shares now-152,167
New positions and exits
New (0)
No new position among listed positions.
Exited (4)
- Holocene Advisors LPwas $89m
- Two Sigma Investments LPwas $67m
- Two Sigma Advisers LPwas $28m
- Maverick Capital Ltdwas $1.2m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2022 | 1 | $371m | n.a. | n.a. |
| Q1 2023 | 13 | $8.0bn | n.a. | n.a. |
| Q2 2023 | 21 | $8.7bn | n.a. | n.a. |
| Q3 2023 | 14 | $6.6bn | n.a. | n.a. |
| Q4 2023 | 13 | $7.3bn | 7 | 8 |
| Q1 2024 | 17 | $9.7bn | 10 | 5 |
| Q2 2024 | 17 | $8.0bn | 9 | 5 |
| Q3 2024 | 20 | $10.7bn | 9 | 11 |
| Q4 2024 | 18 | $8.8bn | 10 | 6 |
| Q1 2025 | 18 | $8.4bn | 9 | 11 |
| Q2 2025 | 22 | $7.2bn | 15 | 6 |
| Q3 2025 | 14 | $6.3bn | 6 | 9 |
| Q4 2025 | 13 | $8.1bn | 17 | 22 |
| Q1 2026 | 11 | $6.3bn | 19 | 18 |
| Q2 2026 | 9 | $4.9bn | 24 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GEHC and LLY →GEHC and JNJ →GEHC and VRTX →Choose a stock to compare with GEHC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GEHC, latest filings →Back to the 13F Explorer →